Picard Medical restructures warrants, slashing exercise price 87% and adding 43% more shares

Filed May 5, 2026 · Period ending May 5, 2026 · ~1 min read

Key Changes

• high

  Company exchanged 7M warrants at $2.675 for 10M new warrants at $0.35, increasing potential dilution by 43% while making exercise far more likely at the drastically lower price

  Item 1.01 verify on EDGAR →
• medium

  Removed forced exercise provision that would have converted warrants to equity when stock doubled and stayed elevated for 20 days, allowing warrants to remain outstanding indefinitely

  Item 1.01 verify on EDGAR →
• medium

  Eliminated anti-dilution ratchet that previously lowered exercise price and increased share count if company issued cheap stock, trading future protection for upfront lower price

  Item 1.01 verify on EDGAR →